RCKT
Rocket Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$390.85M
P/E Ratio
—
EPS
$-2.08
Beta
0.57
52W High
$8.26
52W Low
$2.19
50-Day MA
$4.02
200-Day MA
$3.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-217.49M |
| Operating Margin | 0.00% |
| Return on Equity | -60.30% |
| Return on Assets | -33.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.56 |
| Price-to-Book | 1.39 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $108.57M |
| Float | $86.97M |
| % Insiders | 4.42% |
| % Institutions | 84.53% |
Analyst Ratings
Consensus ($8.48 target)
6
Buy6
Hold1
Sell1
Strong SellData last updated: 4/9/2026